Kim Daeseung, Kim Jeong Seon, Cheon Inyoung, Kim Seo Ree, Chun Sang Hoon, Kim Jae Jun, Lee Sieun, Yoon Jung Sook, Hong Soon Auck, Won Hye Sung, Kang Keunsoo, Ahn Young-Ho, Ko Yoon Ho
Deargen Inc., Daejeon 34051, Korea.
Department of Molecular Medicine and Inflammation-Cancer Microenvironment Research Center, College of Medicine, Ewha Womans University, Seoul 07804, Korea.
Cancers (Basel). 2022 Jul 18;14(14):3486. doi: 10.3390/cancers14143486.
Cancer-associated fibroblasts (CAFs) reside within the tumor microenvironment, facilitating cancer progression and metastasis via direct and indirect interactions with cancer cells and other stromal cell types. CAFs are composed of heterogeneous subpopulations of activated fibroblasts, including myofibroblastic, inflammatory, and immunosuppressive CAFs. In this study, we sought to identify subpopulations of CAFs isolated from human lung adenocarcinomas and describe their transcriptomic and functional characteristics through single-cell RNA sequencing (scRNA-seq) and subsequent bioinformatics analyses. Cell trajectory analysis of combined total and THY1 + CAFs revealed two branching points with five distinct branches. Based on Gene Ontology analysis, we denoted Branch 1 as "immunosuppressive", Branch 2 as "neoantigen presenting", Branch 4 as "myofibroblastic", and Branch 5 as "proliferative" CAFs. We selected representative branch-specific markers and measured their expression levels in total and THY1 + CAFs. We also investigated the effects of these markers on CAF activity under coculture with lung cancer cells. This study describes novel subpopulations of CAFs in lung adenocarcinoma, highlighting their potential value as therapeutic targets.
癌症相关成纤维细胞(CAFs)存在于肿瘤微环境中,通过与癌细胞及其他基质细胞类型的直接和间接相互作用促进癌症进展和转移。CAFs由活化成纤维细胞的异质性亚群组成,包括肌成纤维细胞性、炎性和免疫抑制性CAFs。在本研究中,我们试图鉴定从人肺腺癌中分离出的CAFs亚群,并通过单细胞RNA测序(scRNA-seq)及后续生物信息学分析来描述它们的转录组和功能特征。对总CAFs和THY1+CAFs进行联合细胞轨迹分析,发现了两个分支点和五个不同的分支。基于基因本体分析,我们将分支1命名为“免疫抑制性”CAFs,分支2为“新抗原呈递性”CAFs,分支4为“肌成纤维细胞性”CAFs,分支5为“增殖性”CAFs。我们选择了具有代表性的分支特异性标志物,并检测了它们在总CAFs和THY1+CAFs中的表达水平。我们还研究了这些标志物在与肺癌细胞共培养时对CAF活性的影响。本研究描述了肺腺癌中CAFs的新亚群,突出了它们作为治疗靶点的潜在价值。